title: [The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
authors.forename: Antonino G M
authors.initials: AG
authors.lastname: Marullo
authors.forename: Angela L
authors.initials: AL
authors.lastname: Iacò
authors.forename: Antonio Maria
authors.initials: AM
authors.lastname: Calafiore
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001021:Aortic Valve / Q000601:surgery*; D001241:Aspirin / Q000627:therapeutic use*; D001705:Bioprosthesis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D011182:Postoperative Care; D011183:Postoperative Complications / Q000517:prevention & control*; D013927:Thrombosis / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin